Episode 4 - Dr. Ian Tannock

#4) BG is joined by Dr. Ian Tannock, Professor Emeritus from the University of Toronto and Princess Margaret Cancer Centre. In this episode we discuss how Dr. Tannock started his career in oncology and clinical trials (4:40), how he then became a clinical trials (14:12), cancer of the great toe (19:45), the Canadian mitoxantrone–prednisone trial (26:00), TAX-327 (32:00), experiences as a mentor (38:00), the role of industry in medical writing (39:30), Dr. Tannock’s optimism about the future of clinical trials (42:18), financial conflicts of interest (46:00), advice to fellows (48:30), what makes a good mentor (50:55), Dr. Tannock’s “evil red pen”, and more (56:00).